These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18451545)

  • 1. Transdermal delivery of praziquantel: effects of solvents on permeation across rabbit skin.
    Zheng XS; Duan CZ; Xiao ZD; Yao BA
    Biol Pharm Bull; 2008 May; 31(5):1045-8. PubMed ID: 18451545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal evaporation delivery system of praziquantel for schistosomiasis japonicum chemotherapy.
    Wang L; Zheng X; Fang Y; Wang Y; Duan C; Yao B
    J Pharm Sci; 2011 Jul; 100(7):2769-77. PubMed ID: 21319162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
    Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation.
    Gorukanti SR; Li L; Kim KH
    Int J Pharm; 1999 Dec; 192(2):159-72. PubMed ID: 10567747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment.
    de Souza AL; Andreani T; de Oliveira RN; Kiill CP; dos Santos FK; Allegretti SM; Chaud MV; Souto EB; Silva AM; Gremião MP
    Int J Pharm; 2014 Mar; 463(1):31-7. PubMed ID: 24370839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in skin permeation of N,N-diethyl-m-toluamide (DEET) by altering the skin/vehicle partition coefficient.
    Ross1 JS; Shah JC
    J Control Release; 2000 Jul; 67(2-3):211-21. PubMed ID: 10825555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of a novel spot-on formulation of praziquantel for dogs.
    Gutiérrez ML; Di Federico G; Dale JA; Minoia JM; Corrales CD; Schaiquevich P; Wikinski S
    Vet Parasitol; 2017 May; 239():46-49. PubMed ID: 28495196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of buprenorphine through cadaver skin.
    Roy SD; Roos E; Sharma K
    J Pharm Sci; 1994 Feb; 83(2):126-30. PubMed ID: 8169777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of solvents and penetration enhancers on transdermal delivery of thymoquinone: permeability and skin deposition study.
    Haq A; Michniak-Kohn B
    Drug Deliv; 2018 Nov; 25(1):1943-1949. PubMed ID: 30463442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhizin-Assisted Transport of Praziquantel Anthelmintic Drug through the Lipid Membrane: An Experiment and MD Simulation.
    Kim AV; Shelepova EA; Selyutina OY; Meteleva ES; Dushkin AV; Medvedev NN; Polyakov NE; Lyakhov NZ
    Mol Pharm; 2019 Jul; 16(7):3188-3198. PubMed ID: 31198045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric Nanostructured Systems for Liquid Formulation of Praziquan-tel: Development and in vitro Assessment.
    de Campos VE; Silva JA; Ricci-Júnior E; Mansur CR; Conti DS; da Rocha SR
    Curr Drug Deliv; 2016; 13(2):287-97. PubMed ID: 26321094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.
    de Jesus MB; Pinto Lde M; Fraceto LF; Magalhães LA; Zanotti-Magalhães EM; de Paula E
    J Drug Target; 2010 Jan; 18(1):21-6. PubMed ID: 19624246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and optimization of thermosensitive nanoemulsion hydrogel for sustained-release of praziquantel.
    Cong Z; Shi Y; Peng X; Wei B; Wang Y; Li J; Li J; Li J
    Drug Dev Ind Pharm; 2017 Apr; 43(4):558-573. PubMed ID: 27935330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pharmacokinetics and therapeutic efficacy of praziquantel and 4-hydroxypraziquantel in Schistosoma japonicum-infected rabbits after oral, rectal, and intramuscular administration.
    Xiao SH; You JQ; Guo HF
    Am J Trop Med Hyg; 1992 May; 46(5):582-8. PubMed ID: 1599052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations.
    Mura P; Faucci MT; Bramanti G; Corti P
    Eur J Pharm Sci; 2000 Feb; 9(4):365-72. PubMed ID: 10664476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacokinetic evaluation of praziquantel loaded in poly (methyl methacrylate) nanoparticle using a HPLC-MS/MS.
    Malhado M; Pinto DP; Silva AC; Silveira GP; Pereira HM; Santos JG; Guilarducci-Ferraz CV; Viçosa AL; Nele M; Fonseca LB; Pinto JC; Calil-Elias S
    J Pharm Biomed Anal; 2016 Jan; 117():405-12. PubMed ID: 26440288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
    Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on transdermal absorption characteristics of brucine in vitro].
    Chen J; Hu W; Cai BC; Hu MM
    Zhong Yao Cai; 2008 Mar; 31(3):445-7. PubMed ID: 18619255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The research on biotransformation of praziquantel.
    Godawska-Matysik A; Pekala E; Kieć-Kononowicz K
    Acta Pol Pharm; 2004 Dec; 61 Suppl():75-8. PubMed ID: 15909947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.